The Current Ratio as of November 2025 (TTM) for Generex Biotechnology Corporation (GNBT) is 0.03

According to Generex Biotechnology Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 0.03. This represents a change of -11.77% compared to the average of 0.03 of the last 4 quarters.

Generex Biotechnology Corporation (GNBT) Historical Current Ratio (quarterly & annually)

How has GNBT Current Ratio performed in the past?

The mean historical Current Ratio of Generex Biotechnology Corporation over the last ten years is 0.14. The current 0.03 Current Ratio has changed 2.03% with respect to the historical average. Over the past ten years (40 quarters), GNBT's Current Ratio was at its highest in in the April 2014 quarter at 0.51. The Current Ratio was at its lowest in in the October 2016 quarter at 0.00.

Generex Biotechnology Corporation (GNBT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Generex Biotechnology Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Generex Biotechnology Corporation (GNBT) Average Current Ratio

How has GNBT Current Ratio performed in the past?

The current Current Ratio of Generex Biotechnology Corporation (GNBT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Generex Biotechnology Corporation (GNBT) Current Ratio vs. Peers

How is GNBT’s Current Ratio compared to its peers?

Generex Biotechnology Corporation’s Current Ratio is less than Predictive Technology Group, Inc. (0.37), less than Endo International plc (1.67), less than Clarus Therapeutics Holdings, Inc. (0.78), less than Propanc Biopharma, Inc. (2.45), less than Nexeon MedSystems Inc. (1.16), less than Health-Chem Corporation (0.20), less than Invitae Corporation (6.41), less than Aleafia Health Inc. (1.01), less than Humanigen, Inc. (0), less than TRACON Pharmaceuticals, Inc. (0.89),

Build a custom stock screener for Generex Biotechnology Corporation (GNBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Generex Biotechnology Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Generex Biotechnology Corporation (GNBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Generex Biotechnology Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.